康基医疗(09997)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09997 康基医疗

停牌 01-21 09:04:34

9.200

+0.000

0.00%

最高9.200	最低9.200	成交量0.00
今开9.200	昨收9.200	日振幅0.00%
总市值111.14亿	流通市值111.14亿	总股本12.08亿
成交额0.00	换手率0.00%	流通股本12.08亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09997","market":"HK","secType":"STK","nameCN":"康基医疗","latestPrice":9.2,"timestamp":1768957474203,"preClose":9.2,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":1208000000,"shares":1208000000,"eps":0.494525,"marketStatus":"停牌","change":0,"latestTime":"01-21 09:04:34","open":9.2,"high":9.2,"low":9.2,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.521781,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768959000000},"marketStatusCode":1,"adr":0,"listingDate":1593360000000,"exchange":"SEHK","adjPreClose":9.2,"dividendRate":0.028402,"openAndCloseTimeList":[[1768959000000,1768968000000],[1768971600000,1768982400000]],"volumeRatio":0,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09997","defaultTab":"news","newsList":[{"id":"2604116391","title":"透景生命（300642）披露全资子公司取得医疗器械注册证，1月20日股价下跌1.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604116391","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604116391?lang=zh_cn&edition=full","pubTime":"2026-01-20 22:24","pubTimestamp":1768919057,"startTime":"0","endTime":"0","summary":"截至2026年1月20日收盘，透景生命报收于19.71元，较前一交易日下跌1.5%，最新总市值为32.04亿元。公司近日发布公告称，其全资子公司上海透景诊断科技有限公司取得上海市药品监督管理局颁发的1项医疗器械注册证，产品名称为25-羟基维生素D测定试剂盒，注册证编号沪械注准20262400019，有效期至2031年01月17日。该产品用于体外定量检测人血清和血浆中25-羟基维生素D浓度，适用于维生素D缺乏相关疾病的辅助诊断。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012000039682.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","09996","BK0042","159883","BK1100","300642","BK0239","BK1222","BK1574","09997","BK0046"],"gpt_icon":0},{"id":"2604751167","title":"之江生物最新公告：公司产品获得马来西亚医疗器械认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2604751167","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604751167?lang=zh_cn&edition=full","pubTime":"2026-01-20 15:42","pubTimestamp":1768894936,"startTime":"0","endTime":"0","summary":"之江生物(688317.SH)公告称，公司全资子公司上海之江生物医药科技有限公司的全自动核酸提取仪（EX3600）近期获得马来西亚医疗器械管理局认证，可在马来西亚进行销售。该认证有助于提升公司国际竞争力，并推动海外销售产品品类及国际业务拓展。然而，产品面临市场竞争风险，且其销售额及利润贡献存在较大不确定性，对公司整体收入的影响也存在不确定性。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012000018730.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK0239","159883","BK1100","09996","BK1222","688317","09997","BK1574"],"gpt_icon":0},{"id":"2604713143","title":"乐心医疗（300562）披露获得医疗器械注册证，1月19日股价下跌0.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604713143","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604713143?lang=zh_cn&edition=full","pubTime":"2026-01-19 22:39","pubTimestamp":1768833551,"startTime":"0","endTime":"0","summary":"截至2026年1月19日收盘，乐心医疗报收于15.15元，较前一交易日下跌0.98%，最新总市值为33.12亿元。该股当日开盘15.19元，最高15.4元，最低14.95元，成交额达1.85亿元，换手率为7.5%。同日，乐心医疗发布公告称，公司近日收到广东省药品监督管理局通知，其申报的血糖仪产品已获II类医疗器械注册证，注册证编号为粤械注准20262220067，型号为GBZ41-B和GBZ41。其中GBZ41-B型号具备蓝牙功能，可将数据上传至指定APP。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900035941.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300562","BK1574","09997","BK1100","159883","BK0114","BK0109","BK0251","09996","BK1222","BK1583"],"gpt_icon":0},{"id":"2604207187","title":"乐心医疗(300562.SZ)取得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2604207187","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604207187?lang=zh_cn&edition=full","pubTime":"2026-01-19 18:28","pubTimestamp":1768818508,"startTime":"0","endTime":"0","summary":"智通财经APP讯，乐心医疗(300562.SZ)公告，公司近日收到广东省药品监督管理局的通知，获悉公司申报的血糖仪医疗器械注册事宜已通过审批。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1394602.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","BK1574","BK1100","159883","09997","09996","BK0109","BK1222","BK0114","BK1583","300562"],"gpt_icon":0},{"id":"2604301401","title":"归创通桥收购德国医疗器械公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2604301401","media":"欧洲并购与投资","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604301401?lang=zh_cn&edition=full","pubTime":"2026-01-19 17:05","pubTimestamp":1768813517,"startTime":"0","endTime":"0","summary":"归创通桥收购德国医疗器械公司图片来源：归创通桥专注于外周和神经血管介入产品及解决方案的香港上市公司归创通桥Zylox-Tonbridge今日宣布，已与德国医疗技术公司Optimed Medizinische Instrumente GmbH达成最终收购协议，将分阶段收购Optimed。Optimed是一家专注于全球微创治疗医疗器械研发、生产和销售的公司。根据协议条款，归创通桥有权从Optimed现有股东手中收购其全部股权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119171549a72bceb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119171549a72bceb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","BK1574","BK1587","09997","09996","BK1222","02190","BK1583"],"gpt_icon":0},{"id":"2604318847","title":"天益医疗获医疗器械注册证 承担血液及液体通路功能","url":"https://stock-news.laohu8.com/highlight/detail?id=2604318847","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604318847?lang=zh_cn&edition=full","pubTime":"2026-01-19 14:18","pubTimestamp":1768803480,"startTime":"0","endTime":"0","summary":"1月19日，天益医疗（301097）发布公告，公司近日收到国家药品监督管理局颁发的《医疗器械注册证》。该产品由多种管路和附件组成，适用于与AQUARIUS系列连续性血液净化装置和专用滤器配套使用，承担血液及液体通路的功能。此次注册证的获得，标志着公司产品持续符合相关监管要求，有助于巩固和扩大市场竞争力。2025年前三季度，天益医疗实现收入3.87亿元，归母净利润2009万元。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/zqgd/2026-01-19/doc-inhhvmxx6933356.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301097","09996","BK1100","159883","09997","BK1222","BK1583","BK0251","BK1574"],"gpt_icon":0},{"id":"2604783039","title":"国货美妆十强重押医美！","url":"https://stock-news.laohu8.com/highlight/detail?id=2604783039","media":"青眼","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604783039?lang=zh_cn&edition=full","pubTime":"2026-01-18 16:47","pubTimestamp":1768726046,"startTime":"0","endTime":"0","summary":"无独有偶，另一国货美妆十强企业巨子生物自主研发的“重组I型α1亚型胶原蛋白及透明质酸钠复合溶液”，也在同一日拿证。事实上，贝泰妮投资的公司与巨子生物旗下产品同日获批2款注射用三类医疗器械证，是国货美妆十强企业集体押注医美的缩影。据青眼不完全统计发现，包含贝泰妮和巨子生物在内的多个国货美妆十强企业，几乎都在医美赛道有所布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260118165543953d358a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260118165543953d358a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09997","BK1222","BK1583","02367","SG9999004311.SGD","09996","BK1100","BK1207","BK1574","LU2488822045.USD"],"gpt_icon":0},{"id":"2603985126","title":"翔宇医疗：“面向难治性抑郁症的闭环经颅刺激系统”项目入围2025年人工智能医疗器械创新任务揭榜挂帅名单","url":"https://stock-news.laohu8.com/highlight/detail?id=2603985126","media":"证券日报 ","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603985126?lang=zh_cn&edition=full","pubTime":"2026-01-15 21:37","pubTimestamp":1768484220,"startTime":"0","endTime":"0","summary":"证券日报网讯 1月15日，翔宇医疗在互动平台回答投资者提问时表示，近日，公司牵头申报的“面向难治性抑郁症的闭环经颅刺激系统”项目成功入围2025年人工智能医疗器械创新任务揭榜挂帅名单。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-01-15/doc-inhhmamp3180317.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-01-15/doc-inhhmamp3180317.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159883","09996","09997","161631","BK1100","688626","BK1583","BK1574","BK1222","BK0251"],"gpt_icon":0},{"id":"2603395608","title":"巨子生物(02367)全资子公司收到国家药监局颁发的关于重组I型α1亚型胶原蛋白及透明质酸钠复合溶液产品的《中华人民共和国医疗器械注册证》","url":"https://stock-news.laohu8.com/highlight/detail?id=2603395608","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603395608?lang=zh_cn&edition=full","pubTime":"2026-01-15 17:13","pubTimestamp":1768468380,"startTime":"0","endTime":"0","summary":"智通财经APP讯，巨子生物 发布公告，本公司全资子公司陕西巨子生物技术有限公司于今日收到中国国家药品监督管理局颁发的关于重组I型α1亚型胶原蛋白及透明质酸钠复合溶液产品(本产品)的《中华人民共和国医疗器械注册证》。本产品以重组胶原蛋白及透明质酸钠为主要成分，用于真皮层的注射，以改善面颊部平滑度。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393337.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2488822045.USD","09996","BK1100","BK1207","SG9999004311.SGD","159883","09997","BK1222","BK1583","BK1574","02367"],"gpt_icon":1},{"id":"2603677369","title":"爱美客：公司主营业务为Ⅲ类医疗器械","url":"https://stock-news.laohu8.com/highlight/detail?id=2603677369","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603677369?lang=zh_cn&edition=full","pubTime":"2026-01-15 16:24","pubTimestamp":1768465487,"startTime":"0","endTime":"0","summary":"证券之星消息，爱美客(300896)01月15日在投资者关系平台上答复投资者关心的问题。投资者提问：你们有没有使用AI技术进行医疗美容？爱美客回复：尊敬的投资者您好，公司主营业务为Ⅲ类医疗器械，是Ⅲ类医疗器械的提供商。公司下游客户主要为有资质的医疗美容机构及经销商，下游客户根据法律法规及其合法资质独立对外开展医疗服务。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500024154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","BK1100","09997","BK1222","09996","BK1583","BK0251","BK1574","300896"],"gpt_icon":0},{"id":"2603162658","title":"嘉事堂：加强药品医疗器械销售配送业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2603162658","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603162658?lang=zh_cn&edition=full","pubTime":"2026-01-15 08:54","pubTimestamp":1768438449,"startTime":"0","endTime":"0","summary":"公司的互联网嘉事堂药店和互联网药店网目前也在正常运营，完全锲合目前的Ai医疗，证明了公司的远见和前瞻。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500006560.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK1583","09997","BK1222","BK0097","BK0250","BK1100","BK0028","159883","002462","09996"],"gpt_icon":0},{"id":"2603640558","title":"【ETF动向】1月14日平安医药及医疗器械创新ETF基金跌0.78%，份额增加1.06亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2603640558","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603640558?lang=zh_cn&edition=full","pubTime":"2026-01-15 06:31","pubTimestamp":1768429909,"startTime":"0","endTime":"0","summary":"证券之星消息，1月14日，平安医药及医疗器械创新ETF基金（516820）跌0.78%，成交额1.41亿元。当日份额增加了1.06亿份，最新份额为46.28亿份，近20个交易日份额增加2.22亿份。当日资金净流入2620.75万元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为17.56亿元。平安医药及医疗器械创新ETF基金跟踪标的为中证医药及医疗器械创新指数，成立（2021-06-09）以来超额回报为2.07%，近一个月超额回报为0.29%，管理人为平安基金公司，基金经理为翁欣 白圭尧。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500004072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","BK1161","BK1515","BK1100","09997","BK1222","09996","159987","BK1574","BK1583","159938","09939"],"gpt_icon":0},{"id":"2603969345","title":"国药一致：目前无代理脑机接口医疗器械","url":"https://stock-news.laohu8.com/highlight/detail?id=2603969345","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603969345?lang=zh_cn&edition=full","pubTime":"2026-01-14 16:09","pubTimestamp":1768378147,"startTime":"0","endTime":"0","summary":"证券之星消息，国药一致(000028)01月14日在投资者关系平台上答复投资者关心的问题。投资者提问：脑机接口是前沿学科，市场前景广阔，公司作为国内医药及医疗器械分销龙头之一，是否与脑机接口医疗器械相关公司达成了合作或代理意向？国药一致回复：感谢您的关注！公司作为医药分销企业会争取尽可能多的合作资源，目前无代理。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400023492.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0185","BK0082","BK0175","000028","BK0250","09996","BK1100","159883","BK0028","BK1574","BK1222","BK0188","09997","BK0010","BK1583"],"gpt_icon":0},{"id":"2603665925","title":"西安高新：臻泰智能再获医疗器械注册证！用“意念”进行语言认知康复","url":"https://stock-news.laohu8.com/highlight/detail?id=2603665925","media":"陕西法制网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603665925?lang=zh_cn&edition=full","pubTime":"2026-01-14 11:26","pubTimestamp":1768361160,"startTime":"0","endTime":"0","summary":"近日，西安高新区企业西安臻泰智能科技有限公司在脑机接口医疗康复领域取得重要进展。至此，臻泰智能在脑机接口康复领域相关产品注册证已增至4张，进一步巩固了其在创新康复医疗技术方面的领先地位。臻泰智能此次获批的“言语与认知功能康复训练评估系统”，能够帮助脑卒中及其他脑损伤导致的言语、记忆等认知障碍患者进行康复。目前，臻泰智能的全系列脑机康复产品已进入全国超300家医院，累计服务患者约十万人次。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-01-14/doc-inhhfvyz4204787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK1100","09997","159883","09996","BK1222","BK1583"],"gpt_icon":0},{"id":"2603771315","title":"港股异动 | 堃博医疗-B(02216)涨近10% BroncTarget®系统进入创新医疗器械特别审查程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2603771315","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603771315?lang=zh_cn&edition=full","pubTime":"2026-01-13 13:49","pubTimestamp":1768283357,"startTime":"0","endTime":"0","summary":"消息面上，1月12日晚，堃博医疗发布公告称，旗下BroncTarget肺部靶向去神经射频消融系统正式进入中国国家药品监督管理局的创新医疗器械特别审查程序，标志着该产品在核心技术原创性、临床价值显著性等方面获得国家药监部门的认可。目前，BroncTarget系统的确证性临床试验正在有序开展中，全国28家医院正同步推进受试者招募。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392105.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09996","BK1583","159883","BK1574","09997","BK1222","BK1100","02216"],"gpt_icon":0},{"id":"2602517496","title":"堃博医疗-B(02216)：BroncTarget®肺部靶向去神经射频消融系统进入创新医疗器械特别审查程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2602517496","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602517496?lang=zh_cn&edition=full","pubTime":"2026-01-12 20:58","pubTimestamp":1768222714,"startTime":"0","endTime":"0","summary":"智通财经APP讯，堃博医疗-B 发布公告，旗下BroncTarget肺部靶向去神经射频消融系统正式进入中国国家药品监督管理局的创新医疗器械特别审查程序，标志着该产品在核心技术原创性、临床价值显著性等方面获得国家药监部门的认可。目前，BroncTarget系统的确证性临床试验正在有序开展中，全国28家医院正同步推进受试者招募。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391860.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09996","BK1574","02216","BK1583","BK1100","159883","09997","BK1222"],"gpt_icon":0},{"id":"2602971205","title":"透景生命(300642.SZ)：骨髓增生异常综合征染色体及基因异常检测试剂盒(荧光原位杂交法)医疗器械注册获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2602971205","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602971205?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:47","pubTimestamp":1768207625,"startTime":"0","endTime":"0","summary":"40%-70%的原发性骨髓增生异常综合征患者在初诊时便存在染色体异常。应用骨髓增生异常综合征组套探针进行荧光原位杂交检测，可提高部分患者细胞遗传学异常检出率。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391612.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300642","09997","BK0046","BK1574","BK1583","159883","BK0042","09996","BK0239","BK1100","BK1222"],"gpt_icon":0},{"id":"2602506564","title":"国泰海通证券：维持威高股份(01066)“增持”评级 医疗器械旗舰平台定位进一步明确","url":"https://stock-news.laohu8.com/highlight/detail?id=2602506564","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602506564?lang=zh_cn&edition=full","pubTime":"2026-01-12 09:53","pubTimestamp":1768182795,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，国泰海通证券发布研报称，维持威高股份“增持”评级，给予目标价7.84港元，威高血净拟发行股份收购威高普瑞全部股权，通过此次整合，威高股份将成为威高血净的控股股东，进一步明确其作为集团旗下医疗器械旗舰平台的定位。公司医疗器械旗舰平台定位进一步明确交易后，公司将持有威高血净52.10%股权，成为其控股股东并合并财务报表。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391414.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01066","161027","09996","09997","159883","02611"],"gpt_icon":0},{"id":"2602541216","title":"医疗器械2026年度策略：把握出海陡峭曲线 卡位AI医疗商业化落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2602541216","media":"华福证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602541216?lang=zh_cn&edition=full","pubTime":"2026-01-12 00:00","pubTimestamp":1768147200,"startTime":"0","endTime":"0","summary":"AI应用、脑机接口：自上而下，把握产业大周期下商业化开启阶段十五五”规划开年，预计后续开年财政也将会释放更积极信号，重视超跌底部AI医疗应用机会。建议关注组合战略组合微创医疗微电生理联影医疗迈瑞医疗弹性组合瑞迈特天智航微创机器人康众医疗润达医疗风险提示：海外商业化不及预期的风险，临床及获批进度不及预期的风险，市场竞争加剧风险，集采政策不及预期的风险，新技术商业化不及预期的风险","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112205142a4babe94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112205142a4babe94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1617","09996","BK1100","BK1574","BK1222","BK1583","09997","02252"],"gpt_icon":0},{"id":"2602038551","title":"医疗器械行业周报","url":"https://stock-news.laohu8.com/highlight/detail?id=2602038551","media":"中信建投证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602038551?lang=zh_cn&edition=full","pubTime":"2026-01-11 00:00","pubTimestamp":1768060800,"startTime":"0","endTime":"0","summary":"建议持续关注市场空间大、国产化率低的创新器械赛道，以及并购重组、脑机接口、AI医疗、手术机器人、外骨骼机器人等主题方向的投资机会。潜在催化较多的方向有望出现涨幅数倍的个股，未来AI医疗、脑机接口等也有望成为投资人重点关注的新科技方向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260111165652a70d4376&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260111165652a70d4376&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09996","01302","BK1100","09997","BK1222","BK1583","BK1574","BK1600"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hzkangji.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0.02},{"period":"6month","weight":0.0926},{"period":"1year","weight":0.5789},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0134},{"period":"1month","weight":0.031},{"period":"3month","weight":0.0274},{"period":"6month","weight":0.032},{"period":"1year","weight":0.3293},{"period":"ytd","weight":0.0334}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康基医疗控股有限公司是一家主要从事微创外科手术器械及配件的设计、开发、制造及销售业务的投资控股公司。该公司的一次性产品包括一次性套管穿刺器、高分子结扎夹、一次性电凝钳、超声切割止血刀及其他一次性产品。重复性产品包括4K内窥镜摄像系统和其他重复性产品。该公司的产品应用于妇产科、泌尿外科、普通外科和胸外科等领域。该公司产品销往国内外市场。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.033993},{"month":2,"riseRate":0.6,"avgChangeRate":0.022159},{"month":3,"riseRate":0.4,"avgChangeRate":-0.018922},{"month":4,"riseRate":0.8,"avgChangeRate":0.100121},{"month":5,"riseRate":0.6,"avgChangeRate":0.009096},{"month":6,"riseRate":0.2,"avgChangeRate":-0.008486},{"month":7,"riseRate":0.5,"avgChangeRate":-0.023464},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.060866},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.058003},{"month":10,"riseRate":0.5,"avgChangeRate":0.001037},{"month":11,"riseRate":0.666667,"avgChangeRate":0.032731},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.02268}],"exchange":"SEHK","name":"康基医疗","nameEN":"KANGJI MEDICAL"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康基医疗(09997)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康基医疗(09997)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康基医疗,09997,康基医疗股票,康基医疗股票老虎,康基医疗股票老虎国际,康基医疗行情,康基医疗股票行情,康基医疗股价,康基医疗股市,康基医疗股票价格,康基医疗股票交易,康基医疗股票购买,康基医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康基医疗(09997)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康基医疗(09997)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}